BusinessSera Prognostics is Named a 2017 Silver Edison Award WinnerBy Nasdaq OMXApr 21, 2017, 11:00 AM UTC
BusinessResearch on Fetal Sex Differences in Predicting Spontaneous Preterm Birth Using Sera’s Proteomic Technology to be Presented at The 64th Annual Society for Reproductive Investigation MeetingBy Nasdaq OMXMar 13, 2017, 6:00 PM UTC
BusinessResearch on Underlying Mechanisms of Pregnancy Complications and Medical Interventions Using Sera’s Proteomic Technology to be Presented at the Society for Maternal-Fetal Medicine’s 37th Annual Pregnancy MeetingBy Nasdaq OMXJan 23, 2017, 8:09 PM UTC
BusinessSera Prognostics Enters into Agreement with LabCorp to be the Exclusive U.S. Distributor of PreTRM® TestBy Nasdaq OMXJan 10, 2017, 12:01 PM UTC
BusinessSera Prognostics Enters into Agreement with LabCorp to be the Exclusive U.S. Distributor of PreTRM® TestBy Nasdaq OMXJan 10, 2017, 12:01 PM UTC
BusinessSera Prognostics to Present at 35th Annual J.P. Morgan Healthcare ConferenceBy Nasdaq OMXJan 3, 2017, 3:00 PM UTC
BusinessTwo Peer-Reviewed Publications Highlight Clinical Utility of PreTRM® TestBy Nasdaq OMXDec 19, 2016, 2:00 PM UTC
